Essity: Interim Report, Quarter 3, 2024
STOCKHOLM, Oct. 24, 2024 /PRNewswire/ — Quarter 3, 2024 – Profitable growth and higher market shares Net sales decreased 2.2% to SEK 36,274m (37,092) Organic growth amounted to 1.9%, of which volume accounted for 2.0% and price/mix -0.1%. Excluding restructuring, organic growth increase
Salt cavern energy storage brings green wealth: Greater Bay Area media visits Shandong to witness a new era of economic development
TAIAN, China, Oct. 24, 2024 /PRNewswire/ — This is a report from the Shandong office of Hong Kong Business Daily. On October 22-25, the Information Office of the People’s Government of Shandong Province hosted the 2024 Guangdong Hong Kong Macao Greater Bay Area mainstream media visit t
" title="Founder of Hua Medicine Dr. Li CHEN was awarded the “C.C. Tan Life Science Industrialization Award”
SHANGHAI, Oct. 24, 2024 /PRNewswire/ — The 17th “C.C. Tan Life Science Award” ceremony was held in Shenyang, China, on October 9th. Dr. Li CHEN, Founder and Chief Executive Officer of Hua Medicine, was awarded the “C.C. Tan Life Science Industrialization Award”. C.C.
dsm-firmenich receives validation from the Science Based Targets initiative for its 2045 net-zero targets
KAISERAUGST, Switzerland and MAASTRICHT, Netherlands, Oct. 24, 2024 /PRNewswire/ — dsm-firmenich, innovators in nutrition, health, and beauty, today announces that its near-term and long-term climate targets have been validated by the Science Based Targets Initiative (SBTi). By focusing on cli
" title="“K” LINE to trial Inmarsat Maritime’s new bonded network service NexusWave on “K” LINE’s fleet
LONDON, Oct. 24, 2024 /PRNewswire/ — Kawasaki Kisen Kaisha, Ltd. (“K” LINE) and Inmarsat Maritime, a Viasat company, are pleased to announce that “K” LINE will conduct a trial of Inmarsat Maritime’s new bonded network service NexusWave on “K” LINE
J INTS BIO Presents Interim Findings from Phase 1/2 Clinical Trial of 4th-Generation EGFR-TKI ‘JIN-A02’ in NSCLC: A Potential Breakthrough in Overcoming Acquired Resistance to Targeted Therapy
SEOUL, South Korea, Oct. 24, 2024 /PRNewswire/ — J INTS BIO, a pioneering biopharmaceutical company, has unveiled promising interim results from the Phase 1/2 clinical trial of its novel 4th-generation EGFR Tyrosine Kinase Inhibitor (TKI), JIN-A02, aimed at EGFR-mutated non-small cell lung can
Horizon Robotics Officially Lists on the Hong Kong Stock Exchange
HONG KONG, Oct. 24, 2024 /PRNewswire/ — Horizon Robotics (HKEX: 9660), a leading provider of advanced driver assistance systems (ADAS) and autonomous driving (AD) solutions for passenger vehicles, today officially listed on the Main Board of the Hong Kong Stock Exchange. Horizon Robotics is a
Global Times: Xi advocates high quality development of greater BRICS cooperation
BEIJING, Oct. 24, 2024 /PRNewswire/ — Chinese President Xi Jinping on Wednesday called on BRICS members to conform to the general trend of the rise of the Global South and actively respond to the call of countries to join the BRICS cooperation mechanism. The group should advance the process o
AI Adoption in 2024: 74% of Companies Struggle to Achieve and Scale Value
New BCG Research on AI Adoption Identifies Fintech, Software, and Banking as the Sectors with the Highest Concentration of AI Leaders BOSTON, Oct. 24, 2024 /PRNewswire/ — After years of investing, hiring talent, and launching pilots in artificial intelligence (AI), CEOs are now seeking tangibl
HOME EQUITY GAINS LEVEL OFF AS U.S. HOUSING MARKET COOLS DOWN DURING THIRD QUARTER OF 2024
Almost Half of Mortgaged Homeowners Remain Equity-Rich; Portion of Owners Seriously Underwater Still Close to Five-Year Low; IRVINE, Calif., Oct. 24, 2024 /PRNewswire/ — ATTOM, a leading curator of land, property data, and real estate analytics, today released its third quarter 2024 U.S. Hom
